About this trial
The TERdeblue-S study is a feasibility study of robotic remote echocardiography, not only in terms of technology but also in terms of its integration into a telemedicine system to improve access to the heart failure management system in the Guadeloupe archipelago. The main objective of this study is to study the agreement of the measurement of the left ventricular ejection fraction (FejVG) between in situ echocardiography (EIS) and two-dimensional remote echocardiography (TER) (distance and volumes).
Eligibility criteria
Qualifiers
Age ≥18 years
Free, informed and written consent signed by the participant and the investigator
Person affiliated or benefiting from a social security scheme.
Systematic cardiovascular check-up or asymptomatic patient with cardiovascular risk factor (hypertension, diabetes, obesity, tobacco, alcohol)
Disqualifiers
Patient requiring urgent cardiological management with transfer to the University Hospital
Acute unstable heart failure, admission to CH Marie-Galante less than 5 days (less than one week)
Pregnant women
Trial design
Treatments tested in this trial
- in situ echocardiography (EIS)
- two-dimensional remote echocardiography (TER)
Treatment groups
Sponsors and collaborators
Centre Hospitalier Universitaire de la Guadeloupe
Lead sponsor
GIRCI SOHO
Collaborator